Literature DB >> 30552681

Identification of microRNAs related to myocardial ischemic reperfusion injury.

Kang Liu1, Li Ma1, Fang Zhou1, Yingcong Yang1, Hai-Bo Hu2, Long Wang1, Liang Zhong3.   

Abstract

Previous studies have suggested that microRNAs (miRNAs) are associated with the progression of myocardial ischemic reperfusion (I/R) injury. However, inconsistent results have been obtained due to the differences in sequencing platform, control selection, and filtering conditions. To explore the key miRNAs in the pathogenesis of myocardial I/R injury and develop miRNA diagnostic biomarkers for myocardial I/R injury prevention, we performed a systematic analysis of publicly available myocardial I/R injury miRNA expression data and investigated the function of the signature miRNA. A total of 17 representative myocardial I/R injury miRNA datasets were extracted from the Google Scholar website and a systematic bioinformatics analysis was done. TargetScan software was used to predict the miRNA target genes, and functional enrichment and transcription factor binding analyses were performed on the target genes using the DAVID and Tfacts databases. In this study, a total of 10 signature miRNAs associated with myocardial I/R injury were identified, which included eight significantly upregulated miRNAs (miR-let-7b-3p, miR-let-7c-3p, miR-15b-3p, miR-195-3p, miR-21-5p, miR-214-5p, miR-24-3p, and miR-320a) and two significantly downregulated miRNAs (miR-126-5p and miR-499a-5p). They had different influences on myocardial I/R injury. The upregulated target gene-expressing signature messenger RNAs (mRNAs) were mainly involved in the transcriptional regulation process of GO: 0000122, negative regulation of transcription from RNA polymerase II promoter, and so on, while downregulated expression of signature mRNAs was mainly involved in GO:0070534, protein K63-linked ubiquitination, and so forth. To summarize, 10 signature miRNAs of myocardial I/R injury pathogenesis were identified and their target genes and transcription factors were revealed, suggesting the potential novel therapeutic targets for myocardial I/R injury.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  function, microRNA (miRNA), myocardial ischemic reperfusion (I/R) injury, systematic analysis

Year:  2018        PMID: 30552681     DOI: 10.1002/jcp.27795

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  11 in total

1.  Upregulation of miR-499a-5p Decreases Cerebral Ischemia/Reperfusion Injury by Targeting PDCD4.

Authors:  Weifeng Shan; Huifeng Ge; Bingquan Chen; Linger Huang; Shaojun Zhu; Yanfeng Zhou
Journal:  Cell Mol Neurobiol       Date:  2021-04-09       Impact factor: 4.231

2.  Exosomal transfer of miR-15b-3p enhances tumorigenesis and malignant transformation through the DYNLT1/Caspase-3/Caspase-9 signaling pathway in gastric cancer.

Authors:  Shuchun Wei; Lei Peng; Jiajia Yang; Huaiming Sang; Duochen Jin; Xuan Li; Meihong Chen; Weifeng Zhang; Yini Dang; Guoxin Zhang
Journal:  J Exp Clin Cancer Res       Date:  2020-02-10

3.  MicroRNA-21 mediates the protective effects of salidroside against hypoxia/reoxygenation-induced myocardial oxidative stress and inflammatory response.

Authors:  Bing Liu; Huali Wei; Ming Lan; Na Jia; Junmeng Liu; Meng Zhang
Journal:  Exp Ther Med       Date:  2020-01-03       Impact factor: 2.447

4.  Tetrandrine Ameliorates Myocardial Ischemia Reperfusion Injury through miR-202-5p/TRPV2.

Authors:  Wei Zhao; Youyang Wu; Fanhao Ye; Shiwei Huang; Hao Chen; Rui Zhou; Wenbing Jiang
Journal:  Biomed Res Int       Date:  2021-03-08       Impact factor: 3.411

5.  Expression of miRNAs in plasma exosomes derived from patients with atrial fibrillation.

Authors:  Zhang Wei; Zhang Bing; Qian Shaohuan; Wang Yanran; Sun Shuo; Tang Bi; Zhu Feiyu; Zhang Heng; Gao Qin; Kang Pinfang
Journal:  Clin Cardiol       Date:  2020-09-17       Impact factor: 2.882

6.  MiR-126, IL-7, CXCR1/2 receptors, inflammation and circulating endothelial progenitor cells: The study on targets for treatment pathways in a model of subclinical cardiovascular disease (type 1 diabetes mellitus).

Authors:  David J Coulson; Sherin Bakhashab; Jevi Septyani Latief; Jolanta U Weaver
Journal:  J Transl Med       Date:  2021-04-16       Impact factor: 5.531

7.  Predictive value and regulatory mechanism of serum miR-499a-5p on myocardial dysfunction in sepsis.

Authors:  Chuang Yang; Kun Wen
Journal:  J Cardiothorac Surg       Date:  2021-10-15       Impact factor: 1.637

8.  MicroRNA Profiles of Maternal and Neonatal Endothelial Progenitor Cells in Preeclampsia.

Authors:  Lars Brodowski; Bianca Schröder-Heurich; Sandra von Hardenberg; Katja Richter; Constantin S von Kaisenberg; Oliver Dittrich-Breiholz; Nadia Meyer; Thilo Dörk; Frauke von Versen-Höynck
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

9.  miR-15b-3p promotes the malignant progression of endometrial cancer cells through targeting KLF2.

Authors:  Ping Wang; Xiqing Zhao; Xiaotang Wu; Guoshuai Tang; Linna Yuan
Journal:  Cell Cycle       Date:  2021-07-05       Impact factor: 5.173

10.  MicroRNA‑494 suppresses hypoxia/reoxygenation‑induced cardiomyocyte apoptosis and autophagy via the PI3K/AKT/mTOR signaling pathway by targeting SIRT1.

Authors:  Shuwei Ning; Zhiying Li; Zhenyu Ji; Dandan Fan; Keke Wang; Qian Wang; Lei Hua; Junyue Zhang; Xiangguang Meng; Yiqiang Yuan
Journal:  Mol Med Rep       Date:  2020-10-26       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.